Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Glycoconjugate Journal
|
August 24, 2022
Proceedings of workshop: "Neuroglycoproteins in health and disease", INNOGLY cost action
Esther Llop, Ana Ardá, Elsa Zacco, et al.
Mediators of Inflammation
|
January 16, 2018
Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in <i>Pseudomonas aeruginosa</i> Infection of Cystic Fibrosis Bronchial Epithelial Cells
Domitilla Schiumarini, Nicoletta Loberto, Giulia Mancini, et al.
Neurology. Genetics
|
November 19, 2020
The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD
Letizia Straniero, Rosanna Asselta, Salvatore Bonvegna, et al.
Glycoconjugate Journal
|
July 15, 2025
Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells
Dorina Dobi, Alessandro Rimessi, Nicoletta Loberto, et al.
Biomedicines
|
May 27, 2023
GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP
Maria Fazzari, Giulia Lunghi, Alexandre Henriques, et al.
FEBS Open Bio
|
October 27, 2023
GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons
Giulia Lunghi, Erika Di Biase, Emma Veronica Carsana, et al.
International Journal of Molecular Sciences
|
July 1, 2020
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease
Giulia Mancini, Nicoletta Loberto, Debora Olioso, et al.
The Biochemical Journal
|
September 2, 2020
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation
Andrea Ghiroldi, Marco Piccoli, Pasquale Creo, et al.
Scientific Reports
|
February 14, 2017
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
Arianna Bettiga, Massimo Aureli, Giorgia Colciago, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 24, 2024
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
Dinu Zinovie Ciobanu, Nara Liessi, Valeria Tomati, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Glycoconjugate Journal
|
August 24, 2022
Proceedings of workshop: "Neuroglycoproteins in health and disease", INNOGLY cost action
Esther Llop, Ana Ardá, Elsa Zacco, et al.
Mediators of Inflammation
|
January 16, 2018
Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in <i>Pseudomonas aeruginosa</i> Infection of Cystic Fibrosis Bronchial Epithelial Cells
Domitilla Schiumarini, Nicoletta Loberto, Giulia Mancini, et al.
Neurology. Genetics
|
November 19, 2020
The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD
Letizia Straniero, Rosanna Asselta, Salvatore Bonvegna, et al.
Glycoconjugate Journal
|
July 15, 2025
Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells
Dorina Dobi, Alessandro Rimessi, Nicoletta Loberto, et al.
Biomedicines
|
May 27, 2023
GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP
Maria Fazzari, Giulia Lunghi, Alexandre Henriques, et al.
FEBS Open Bio
|
October 27, 2023
GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons
Giulia Lunghi, Erika Di Biase, Emma Veronica Carsana, et al.
International Journal of Molecular Sciences
|
July 1, 2020
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease
Giulia Mancini, Nicoletta Loberto, Debora Olioso, et al.
The Biochemical Journal
|
September 2, 2020
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation
Andrea Ghiroldi, Marco Piccoli, Pasquale Creo, et al.
Scientific Reports
|
February 14, 2017
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
Arianna Bettiga, Massimo Aureli, Giorgia Colciago, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 24, 2024
Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
Dinu Zinovie Ciobanu, Nara Liessi, Valeria Tomati, et al.
Page
of 9